Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Pinney

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Annals of Clinical Biochemistry|March 10, 2012
AmyloidosisJennifer H Pinney, Philip N Hawkins
American Journal of Nephrology|December 24, 2010
Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin responseThomas Oates, Jennifer H Pinney, Andrew Davenport
Nephron. Clinical Practice|July 16, 2011
Haemodiafiltration does not reduce the frequency of intradialytic hypotensive episodes when compared to cooled high-flux haemodialysisJennifer H Pinney, Thomas Oates, Andrew Davenport
Transplantation Proceedings|March 8, 2020
Post-transplant Monoclonal Gammopathy of Renal Significance: A Case SeriesRitika Rana, Paul Cockwell, Guy Pratt, et al.
BMC Nephrology|July 22, 2017
Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain testJennifer L J Heaney, John P Campbell, Punit Yadav, et al.
British Journal of Haematology|June 28, 2017
Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survivalGraham McIlroy, Jemma Mytton, Felicity Evison, et al.
British Journal of Haematology|June 19, 2013
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosisMurielle Roussel, Sajitha Sachchithanantham, Simon D J Gibbs, et al.
Digestive Diseases and Sciences|February 2, 2013
Inflammatory bowel disease and systemic AA amyloidosisPrayman T Sattianayagam, Julian D Gillmore, Jennifer H Pinney, et al.
Blood|February 15, 2012
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survivalChristopher P Venner, Thirusha Lane, Darren Foard, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Annals of Clinical Biochemistry|March 10, 2012
AmyloidosisJennifer H Pinney, Philip N Hawkins
American Journal of Nephrology|December 24, 2010
Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin responseThomas Oates, Jennifer H Pinney, Andrew Davenport
Nephron. Clinical Practice|July 16, 2011
Haemodiafiltration does not reduce the frequency of intradialytic hypotensive episodes when compared to cooled high-flux haemodialysisJennifer H Pinney, Thomas Oates, Andrew Davenport
Transplantation Proceedings|March 8, 2020
Post-transplant Monoclonal Gammopathy of Renal Significance: A Case SeriesRitika Rana, Paul Cockwell, Guy Pratt, et al.
BMC Nephrology|July 22, 2017
Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain testJennifer L J Heaney, John P Campbell, Punit Yadav, et al.
British Journal of Haematology|June 28, 2017
Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survivalGraham McIlroy, Jemma Mytton, Felicity Evison, et al.
British Journal of Haematology|June 19, 2013
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosisMurielle Roussel, Sajitha Sachchithanantham, Simon D J Gibbs, et al.
Digestive Diseases and Sciences|February 2, 2013
Inflammatory bowel disease and systemic AA amyloidosisPrayman T Sattianayagam, Julian D Gillmore, Jennifer H Pinney, et al.
Blood|February 15, 2012
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survivalChristopher P Venner, Thirusha Lane, Darren Foard, et al.
Pageof 3